Skip to main content
. 2020 Aug 11;2020:4540312. doi: 10.1155/2020/4540312

Table 1.

Clinical characteristics of the included studies.

Surname (year) Country Cancer type Sample size High Low Cutoff (high/low) Detection method Clinical features Quality score References
Fei Tao (2018) China Rectal cancer 152 76 76 Median qRT-PCR C; T; H 7 [19]
Guodong Zhang (2019) China Osteosarcoma 60 30 30 Median qRT-PCR C; L 6 [25]
Tao Yang (2017) China Laryngeal cancer 65 33 32 Median qRT-PCR C; L; H 7 [17]
Zhiliang Lu (2017) China NSCLC 110 55 55 Median qRT-PCR C; H; T; L 8 [26]
Wei Huang (2016) China TSCC 96 44 52 Mean qRT-PCR C; H; T 7 [20]
Peng Jiang (2019) China CRC 173 71 102 Mean qRT-PCR C; H; T 6 [21]
Shun Ke (2018) China ESCC 137 68 69 Median qRT-PCR C; H 8 [16]
Ronggao Chen (2020) China HCC 90 45 45 Median qRT-PCR H 7 [24]
Xiaolan Yu (2018) China HCC 54 27 27 Median qRT-PCR NA 7 [22]

NSCLC: non-small-cell lung cancer; TSCC: tongue squamous cell carcinoma; CRC: colorectal cancer; ESCC: esophageal squamous cell carcinoma; HCC: hepatocellular carcinoma; C: clinical stage; H: histological grade; L: lymph node metastasis; T: tumor invasion depth; NA: not available.